These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 26482099)

  • 21. Aiming for allosterism: Evaluation of allosteric modulators of CB1 in a neuronal model.
    Straiker A; Mitjavila J; Yin D; Gibson A; Mackie K
    Pharmacol Res; 2015 Sep; 99():370-6. PubMed ID: 26211948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural dynamics and energetics underlying allosteric inactivation of the cannabinoid receptor CB1.
    Fay JF; Farrens DL
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8469-74. PubMed ID: 26100912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple Binding Sites Contribute to the Mechanism of Mixed Agonistic and Positive Allosteric Modulators of the Cannabinoid CB1 Receptor.
    Saleh N; Hucke O; Kramer G; Schmidt E; Montel F; Lipinski R; Ferger B; Clark T; Hildebrand PW; Tautermann CS
    Angew Chem Int Ed Engl; 2018 Mar; 57(10):2580-2585. PubMed ID: 29314474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of indole-2-carboxamides bearing photoactivatable functionalities as novel allosteric modulators for the cannabinoid CB1 receptor.
    Qiao CJ; Ali HI; Ahn KH; Kolluru S; Kendall DA; Lu D
    Eur J Med Chem; 2016 Oct; 121():517-529. PubMed ID: 27318976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profiling two indole-2-carboxamides for allosteric modulation of the CB1 receptor.
    Ahn KH; Mahmoud MM; Samala S; Lu D; Kendall DA
    J Neurochem; 2013 Mar; 124(5):584-9. PubMed ID: 23205875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The future of type 1 cannabinoid receptor allosteric ligands.
    Alaverdashvili M; Laprairie RB
    Drug Metab Rev; 2018 Feb; 50(1):14-25. PubMed ID: 29355038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In silico mapping of allosteric ligand binding sites in type-1 cannabinoid receptor.
    Sabatucci A; Tortolani D; Dainese E; Maccarrone M
    Biotechnol Appl Biochem; 2018 Jan; 65(1):21-28. PubMed ID: 28833445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The membrane proximal region of the cannabinoid receptor CB1 N-terminus can allosterically modulate ligand affinity.
    Fay JF; Farrens DL
    Biochemistry; 2013 Nov; 52(46):8286-94. PubMed ID: 24206272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing Allosteric Modulation of CB
    Scott CE; Kendall DA
    Methods Enzymol; 2017; 593():317-342. PubMed ID: 28750809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular alliance-from orthosteric and allosteric ligands to dualsteric/bitopic agonists at G protein coupled receptors.
    Mohr K; Schmitz J; Schrage R; Tränkle C; Holzgrabe U
    Angew Chem Int Ed Engl; 2013 Jan; 52(2):508-16. PubMed ID: 23225228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural Insights into CB1 Receptor Biased Signaling.
    Al-Zoubi R; Morales P; Reggio PH
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s).
    Kulkarni PM; Kulkarni AR; Korde A; Tichkule RB; Laprairie RB; Denovan-Wright EM; Zhou H; Janero DR; Zvonok N; Makriyannis A; Cascio MG; Pertwee RG; Thakur GA
    J Med Chem; 2016 Jan; 59(1):44-60. PubMed ID: 26529344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A key agonist-induced conformational change in the cannabinoid receptor CB1 is blocked by the allosteric ligand Org 27569.
    Fay JF; Farrens DL
    J Biol Chem; 2012 Sep; 287(40):33873-82. PubMed ID: 22846992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs.
    Valant C; Sexton PM; Christopoulos A
    Mol Interv; 2009 Jun; 9(3):125-35. PubMed ID: 19592673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol-A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling.
    Jakowiecki J; Abel R; Orzeł U; Pasznik P; Preissner R; Filipek S
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33922473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Constitutive activation drives compartment-selective endocytosis and axonal targeting of type 1 cannabinoid receptors.
    Leterrier C; Lainé J; Darmon M; Boudin H; Rossier J; Lenkei Z
    J Neurosci; 2006 Mar; 26(12):3141-53. PubMed ID: 16554465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-activity relationships of substituted 1H-indole-2-carboxamides as CB1 receptor allosteric modulators.
    Nguyen T; German N; Decker AM; Li JX; Wiley JL; Thomas BF; Kenakin TP; Zhang Y
    Bioorg Med Chem; 2015 May; 23(9):2195-2203. PubMed ID: 25797163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allosteric Modulation of GPCRs of Class A by Cholesterol.
    Jakubík J; El-Fakahany EE
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Membrane cholesterol access into a G-protein-coupled receptor.
    Guixà-González R; Albasanz JL; Rodriguez-Espigares I; Pastor M; Sanz F; Martí-Solano M; Manna M; Martinez-Seara H; Hildebrand PW; Martín M; Selent J
    Nat Commun; 2017 Feb; 8():14505. PubMed ID: 28220900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Palmitoylation of cysteine 415 of CB
    Oddi S; Stepniewski TM; Totaro A; Selent J; Scipioni L; Dufrusine B; Fezza F; Dainese E; Maccarrone M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 May; 1862(5):523-532. PubMed ID: 28215712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.